Combination of Herceptin and chemotherapy improves treatment for women with HER2+ bre

[News]

Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.

More... (http://www.news-medical.net/news/20091214/Combination-of-Herceptin-and-chemotherapy-improves-treatment-for-women-with-HER22b-breast-cancer.aspx)